Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Siebold S. N. de Graaf"'
Autor:
Brenda Gibson, Ian Hann, Chirstine J. Harrison, Siebold S. N. de Graaf, Keith Wheatley, Robert Kerrin Hills, Eva van den Berg, Anthony V. Moorman, Alan Kenneth Burnett, David Grimwade, David Webb
Publikováno v:
Journal of Clinical Oncology, 28, 16, pp. 2674-81
Journal of Clinical Oncology, 28, 2674-81
Journal of Clinical Oncology, 28(16), 2674-2681. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 28, 2674-81
Journal of Clinical Oncology, 28(16), 2674-2681. AMER SOC CLINICAL ONCOLOGY
Purpose Karyotype is an independent indicator of prognosis in acute myeloid leukemia (AML) that is widely applied to risk-adapted therapy. Because AML is rare in children, the true prognostic significance of individual chromosomal abnormalities in th
Autor:
Corrie E.M. Gidding, Glen S. Germain, Michael B. Dilling, Tiny G. J. Meeuwsen-de Boer, Richard A. Ashmun, Siebold S. N. de Graaf, Karen A. Veverka, Willem A. Kamps, Peter J. Houghton
Publikováno v:
Cancer Chemotherapy and Pharmacology, 45, 1, pp. 21-30
Cancer Chemotherapy and Pharmacology, 45, 21-30
Cancer Chemotherapy and Pharmacology, 45, 21-30
Purpose: Recombinant human insulin-like growth factor I (rhIGF-I) has been reported to ameliorate vincristine-induced neuropathy, the dose-limiting side effect of this antimitotic anticancer drug. However, rhIGF-I also might have adverse effects, as
Autor:
Gudmar, Lönnerholm, Britt-Marie, Frost, Jonas, Abrahamsson, Mikael, Behrendtz, Anders, Castor, Erik, Forestier, Mats, Heyman, Donald R A, Uges, Siebold S N, de Graaf
Publikováno v:
British journal of haematology. 142(4)
Vincristine is a key drug in the treatment of childhood and adult acute lymphoblastic leukemia (ALL), and many other childhood malignancies. Despite decades of wide clinical use, no data on the correlation between vincristine pharmacokinetics and lon
Autor:
Aengus O'Marcaigh, Siebold S. N. de Graaf, Charles A. Stiller, Anupama Rao, Keith Wheatley, Robert Kerrin Hills, Brenda Gibson, Ian Hann, David Webb
Publikováno v:
British Journal of Haematology, 132, 5, pp. 576-83
British Journal of Haematology, 132, 576-83
British Journal of Haematology, 132, 576-83
Item does not contain fulltext Down syndrome (DS) children are at an increased risk of developing myelodysplasia and acute myeloid leukaemia (AML). We retrospectively analysed the population-based data on 81 children with myeloid leukaemia of Down sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e23cf443c60fbb5833365d602d68a04c
https://hdl.handle.net/2066/51092
https://hdl.handle.net/2066/51092
Autor:
Stewart J, Kellie, Donald R A, Uges, Pauline, Koopmans, Britt-Marie, Frost, Siebold S N, De Graaf
Publikováno v:
Medical and pediatric oncology. 38(5)
Autor:
Draga Barbaric, John W. Earl, Siebold S. N. de Graaf, Deborah J. Carr, Stewart J. Kellie, Pauline Koopmans
Publikováno v:
Cancer, 94, 1815-20
Cancer, 94(6), 1815-1820. Wiley
Cancer, 94, 6, pp. 1815-20
Cancer, 94(6), 1815-1820. Wiley
Cancer, 94, 6, pp. 1815-20
BACKGROUND Vincristine (VCR) is used widely in oncology practice, and regular dosing is commonly associated with the development of sensorimotor or autonomic neuropathies. However, the incidence of VCR-related central nervous system (CNS) toxicity is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73d4133fb1d0064a6cb82649e07cb675
http://hdl.handle.net/2066/160327
http://hdl.handle.net/2066/160327
Autor:
Stewart J. Kellie, Pauline Koopmans, John Earl, Christa Nath, Derek Roebuck, Donald R. A. Uges, Siebold S. N. de Graaf
Publikováno v:
Cancer (0008543X); Jun2004, Vol. 100 Issue 12, p2637-2643, 7p
Autor:
Wilma P Meeuwsen-Van Der Roest, Willem G. Zijlstra, Siebold S. N. de Graaf, Heimen Schraffordt Koops
Publikováno v:
European journal of cancer & clinical oncology, 23(6), 731-737. PERGAMON-ELSEVIER SCIENCE LTD
Body weight and lean body mass are different reflections of the nutritional status of patients receiving cancer chemotherapy. In the present study, the relation between lean body mass and body weight during cytostatic treatment was investigated in 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a671bebce6d5fa2b3c14880e8de0a19a
https://research.rug.nl/en/publications/9d246f09-32ee-48a1-8c41-b1974e1df575
https://research.rug.nl/en/publications/9d246f09-32ee-48a1-8c41-b1974e1df575